Navigation Links
Potential Key to Brain Blood-Flow Disorders Explored by Scientists

Scientists at University of Vermont have uncovered the possible causes for brain disorders such as stroke, migraine, and Alzheimer’s disease. Their findings were// published November 1, 2006 in the prestigious journal Nature Neuroscience.

The cellular process is responsible for signaling regional blood flow changes in the brain. To function properly, the brain needs to receive an uninterrupted supply of oxygen and glucose, which is provided through an intricate network of blood vessels in the brain.

Different parts of the brain are engaged by every activity, such as analytical thought, piano playing, seeing, hearing, walking, and these regions then require a rapid elevation of blood flow to meet the increased metabolic needs of the relevant brain cells (neurons). Though this cellular activity can be visualized in modern-day functional brain scans, the mechanisms by which these neurons signal blood vessels to dilate and increasing blood flow remain largely unknown, and are central to understanding brain function.

The diameter of blood vessels in the brain can be modulated by extracellular potassium, a common element present inside and outside all cells of the body. Such modulation of vessel diameter permits changes in blood flow to occur in the brain, as well as in other organs and tissues.

With this knowledge, lead study author Mark Nelson, Ph.D., professor and chair of pharmacology at the University of Vermont, set out to determine whether the diameter of cerebral blood vessels in the brain could be modulated under physiological conditions by external potassium ions. To accomplish this, he and his research team studied the communication that takes place between neurons and blood vessels in mouse and rat brains.

The research team discovered early on that neuronal activity appeared to be communicated to the blood vessels through intermediary cells known as astrocytes.

Astrocytes, which compris e about half the brain, had not been thought to play an active role in brain processes, and were thought to serve as the “glue” of the brain. One end of an individual astrocyte forms extensive contacts with thousands of neurons, while the other end surrounds and encases blood vessels. In this way, astrocytes are capable of integrating information from a large number of neurons and translating this information into distinct physiological outcomes, including modulation of blood flow.

In order to try and find out how neurons use astrocytes to communicate rapidly to blood vessels, the team of scientists at the University of Vermont employed highly advanced technologies to observe the movement of ions between the neuron, astrocyte and blood vessel. Using fluorescent dyes and high resolution microscopy, they detected a calcium wave that moves through the astrocyte from points of contacts with active neurons to the parts – called “endfeet” – which encase the blood vessels.

The information from the active neuron is thus encoded as a calcium signal in the astrocyte. This increase in calcium at the endfeet activates a calcium-sensitive protein, known as a potassium (BK) channel, which permits potassium ions to pour out of the astrocytes onto the adjacent muscle cells in the brain artery.

The authors showed that removing the BK channels, either by drugs or genetically, significantly reduced the dilation of the blood vessel in response to brain activity; hence the astrocytic BK channel is an important participant in the signaling mechanism.

The teams next needed to uncover how the muscle cells responsible for determining blood flow in the blood vessel sense an increase in external potassium. To do this, Nelson and his colleagues focused on a potassium-sensitive protein expressed in smooth muscle cells called the inward rectifier potassium channel, which forms the contractile elements of blood vessels. When there is a small eleva tion of external potassium, the activity of these channels increases, causing smooth muscle cells to become less excitable, resulting in relaxation of the cells, dilation of vessels, and hence an increase in local blood flow. Similar to the BK channel, it was found that a reduction of inward rectifier channels prevented dilation of vessels in response to neuronal activity.

These findings support the novel concept that precise and spatially localized release of potassium ions from astrocytes onto blood vessels mediates the rapid transmission of neuronal activity into regional increases in blood flow.

In addition, this mechanism places into a physiological context the well characterized responsiveness of the cerebral circulation to changes in extracellular potassium, and suggests that alterations in astrocytic BK channel or smooth muscle cell inward rectifier potassium channel function could contribute to cerebrovascular disorders including local cerebral ischemia, dementia and Alzheimer’s disease.

This study suggests that these proteins may be novel targets to protect the brain from cerebrovascular disorders. In addition to Nelson, the research team included Jessica Filosa, Ph.D., postdoctoral fellow in pharmacology; Adrian Bonev, Ph.D., research assistant professor of pharmacology; Stephen Straub, Ph.D., postdoctoral fellow in pharmacology; Keith Wilkerson, Ph.D., postdoctoral fellow in pharmacology; and collaborators at Stanford University.

As a follow up to this work, Nelson and Straub published a study in the December 2006 issue of the Journal of General Physiology that investigated the spatial and temporal characteristics of the calcium signals within astrocytic endfeet, and defined the spatial context of vasoactive signals generated by endfeet. This vasodilation was restricted to a short stretch of the vessel centered on the endfoot, suggesting that endfeet function as individual “vasoregulatory units” in the br ain. One of many implications of this work is that any disruption of astrocytic function will compromise blood flow at critical times during brain activity.

This research was supported by grants from the National Institutes of Health National Heart, Lung, and Blood Institute, the American Heart Association, and the Totman Trust for Medical Research.

Source-Eurekalet
SRI
'"/>




Related medicine news :

1. Potential New Cancer Gene Identified
2. Lack of Smell And Its Potential Risks
3. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
4. The Potential Of Cadaver Transplantation Programme In India
5. Another Potential Of Stem Cells Discovered: Used For Growing Cartilage
6. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
7. A Protein In Yoghurt Has The Potential To Fight E. coli
8. Gold Therapy- A Potential Treatment For Autoimmune Diseases
9. Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains
10. Potential Benefits Of New Nanotechnology
11. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs available ... must find the one that works for them. When an inventor from Suisun City, ... worked and decided to share it with others. , He developed a prototype for ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
(Date:12/2/2016)... LYME, Conn. , Dec. 1, 2016  Today, ... has announced the honor of being selected as winners ... include: Simpson Healthcare Executives Website at the PLATINUM level, ... Conversations Training Module at the GOLD Level, and our ... At Simpson Healthcare Executives, we are excited ...
(Date:12/2/2016)... YORK , December 2, 2016 ... of its past losses following Trump,s victory early in ... potential, and fund managers are now predicting an uptick ... at four equities to see how they have fared ... CLDX ), Amicus Therapeutics Inc. (NASDAQ: ...
Breaking Medicine Technology: